Ann Dermatol.  2016 Feb;28(1):110-112. 10.5021/ad.2016.28.1.110.

Evaluation of the Potential Association between NOS Gene Polymorphisms (iNOS G-954C and eNOS G894T) and Psoriasis

• Duan X
• Cheng Y
• Gao L
• Li L
• Wang T
• Zhang M

• KMID: 2429492
• DOI: http://doi.org/10.5021/ad.2016.28.1.110

Abstract

No abstract available.

MeSH Terms

Psoriasis*

Reference

1. Gottlieb AB, Chao C, Dann F. Psoriasis comorbidities. J Dermatolog Treat. 2008; 19:5–21.

2. Singh VK, Mehrotra S, Narayan P, Pandey CM, Agarwal SS. Modulation of autoimmune diseases by nitric oxide. Immunol Res. 2000; 22:1–19.

3. Cals-Grierson MM, Ormerod AD. Nitric oxide function in the skin. Nitric Oxide. 2004; 10:179–193.

4. Ormerod AD, Weller R, Copeland P, Benjamin N, Ralston SH, Grabowksi P, et al. Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res. 1998; 290:3–8.

5. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006; 298:321–328.

6. Hingorani AD. Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep. 2003; 5:19–25.

7. Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, et al. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis. 1999; 180:1994–2002.

8. Senturk N, Kara N, Aydin F, Gunes S, Yuksel EP, Canturk T, et al. Association of eNOS gene polymorphism (Glu298Asp) with psoriasis. J Dermatol Sci. 2006; 44:52–55.

9. Coto-Segura P, Coto E, Mas-Vidal A, Morales B, Alvarez V, Díaz M, et al. Influence of endothelial nitric oxide synthase polymorphisms in psoriasis risk. Arch Dermatol Res. 2011; 303:445–449.